Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia

BACKGROUND: According to the current schizophrenia treatment guidelines, 3 levels of responsiveness to antipsychotic medication exist: those who respond to first-line antipsychotics, those with treatment-resistant schizophrenia who respond to clozapine, and those with clozapine-resistant or ultra-tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldstein, Meghan Elizabeth, Anderson, Valerie Margaret, Pillai, Avinesh, Kydd, Robert R., Russell, Bruce R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438552/
https://www.ncbi.nlm.nih.gov/pubmed/25603859
http://dx.doi.org/10.1093/ijnp/pyu117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438552/
https://www.ncbi.nlm.nih.gov/pubmed/25603859
http://dx.doi.org/10.1093/ijnp/pyu117

Ejemplares similares